Medicographia N° 100 (Vol 31 – N°3 – 2009)

New advances in the treatment of type 2 diabetes

ADVANCE: setting new standards for optimal management of patients with type 2 diabetes. ADVANCE : nouvelles normes pour la prise en charge optimale des patients atteints de diabète de type 2
J. Chalmers

Major findings from ADVANCE: blood pressure–lowering arm
N. R. Poulter
Major findings from the ADVANCE study: glucose-lowering arm
M. E. Cooper
Implications of ADVANCE in the management of blood pressure in diabetic patients
B. Williams
Implications of ADVANCE in the management of glucose lowering in diabetic patients
D. R. Matthews
The burden of vascular disease in diabetes and hypertension: from micro- to macrovascular disease—the “bad loop”
H. A. J. Struijker-Boudier
Advanced glycation end products (AGEs) and their receptors (RAGEs) in diabetic vascular disease
P. Marchetti
How should future guidelines implement the results of ADVANCE?
M. Marre

Is microalbuminuria a marker for microangiopathy or macroangiopathy?
M. Burnier – P. Fioretto – J. Gumprecht – G. Halaby – R. Unnikrishnan and V. Mohan – F. Puchulu – R. Roussel – G. Schernthaner – M. Shestakova – J.-G. Wang, Y. Li, and C.-S. Sheng